Gilead to acquire Tubulis for up to $5 billion to strengthen its oncology portfolio
The acquisition complements Gilead’s existing oncology expertise and development infrastructure
The acquisition complements Gilead’s existing oncology expertise and development infrastructure
36 districts to get advanced ALS, BLS and neonatal ambulances under MEMS 108
9th edition of flagship pharma conference to be held on April 13-14, bringing together policymakers, industry leaders and global stakeholders
Surgeon Yuvaraja operates on a 55-year-old patient at Medical City Hospital Muscat
Scholarships, research grants and industry mentorship framework aim to strengthen India’s pharma R&D ecosystem
At the center of deployment is mlHealth360’s proprietary Scaida AI platform, designed to detect and triage abnormalities in CT scans
The partnership aims to accelerate clinical trial timelines, boost data quality, and improve decision-making for sponsors worldwide
Biopharma companies face persistent hurdles in cell line development, including long timelines, low yields, and high failure rates for novel molecules
The new capital is expected to fund the company through 2029
Subscribe To Our Newsletter & Stay Updated